3407:TSEAsahi Kasei Corporation Analysis

Asahi Kasei is trading at ¥1,673.5, comfortably above its 20‑day (¥1,598.35) and 50‑day (¥1,596.09) SMAs and well above the 200‑day SMA (¥1,394.67), confirming a strong bullish trend. The MACD histogram (+¥16.01) and a bullish MACD signal reinforce upward momentum, while the RSI of 57 indicates the stock is not yet overbought. With a support level near ¥1,488 and resistance at ¥1,759.5, the current price sits 7.9% below the upside target, offering clear short‑term upside potential despite a 30‑day volatility of ~41%. The low beta (~0.26) suggests limited market‑wide risk, and volume is increasing, supporting liquidity.
Fundamentally, the company appears undervalued: its forward PE of 14.3 is half the industry average of 29.5, and the price‑to‑book of 1.09 is near parity with book value. A dividend yield of 2.59% with a 36% payout ratio is sustainable given strong cash balances (¥377 bn) versus debt (¥1,011 bn). Revenue growth of 2.1% and a recent partnership in antiviral therapies add a modest growth catalyst, while the diversified conglomerate model provides resilience. Overall, the blend of attractive valuation, dividend income, and bullish technicals supports a positive outlook.